OptimizeRx Documents
Documents
100
Ticker
OPRX
ISIN
US68401U2042
OptimizeRx SEC Filings
OptimizeRx Documents 2026
This page contains all official documents and SEC filings for OptimizeRx stock (OPRX, ISIN: US68401U2042). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of OptimizeRx's regulatory filings.
OptimizeRx Stock analysis
OptimizeRx The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation.